News & Alerts
-
Aug- 2022 -30 August
New ‘Polypill’ For Heart Patients Promotes Compliance & Reduce Deaths – Study
According to a news report, a new study has shown that convenience is key when it comes to sticking to…
Read More » -
23 August
BCBS Files Suit Against Teva Over “Excessively Priced” Multiple Sclerosis Drug
According to a news report, Blue Cross Blue Shield of Vermont has filed a federal lawsuit accusing Teva Pharmaceuticals of acting anti-competitively…
Read More » -
20 August
FDA Warns Of Incompatible Autoinjector In Multiple Sclerosis Therapy.
The U.S. Food and Drug Administration is alerting patients, caregivers, and health care professionals that autoinjector devices that are optional…
Read More » -
Jul- 2022 -13 July
Implications of Biden’s Executive Order on Abortion Access
On July 8 2022, President Joe Biden signed an executive order to protect access to reproductive healthcare services after the Supreme Court overturned the…
Read More » -
11 July
How Roe Ruling is Hindering Access to Cancer & Arthritis Drug
The recent Supreme Court’s decision to overturn Roe v. Wade isn’t just suppressing access to Plan B and abortion pills: The Washington Post and Time have reported consumers…
Read More » -
9 July
Can Xanax Cause Memory Loss?
Memory is defined as the ability to store, retain, and recall information. The human memory system is divided into the…
Read More » -
Jun- 2022 -30 June
The U.S. Responds To Monkeypox Outbreak With 296k Vaccines
The United States will deploy 296,000 doses of Jynneos monkeypox vaccine — the preferred vaccine — over the coming weeks and is expanding eligibility…
Read More » -
15 June
Ivermectin Does Not Help With COVID-19 Recovery Time – New Study
Ivermectin is a prescription drug. It comes as an oral tablet, topical cream, and topical lotion. Ivermectin oral tablet is…
Read More » -
15 June
FDA Approves World’s 1st Treatment For Alopecia
The FDA approved the nation’s first drug-fighting severe hair loss with the approval of Eli Lilly and Incyte’s systemic, daily pill June…
Read More » -
6 June
FDA Withdraws UKONIQ (umbralisib) Approval Over Safety Concerns
The FDA withdrew approval for a cancer medication known as umbralisib, used to treat marginal zone lymphoma and follicular lymphoma, over safety…
Read More »